TABLE 4.
Summary of 2019 ACC/AHA Performance and Quality Measures for the Diagnosis and Management of HBP
| Measure No. | Measure Title/Description | ACC/AHA Stage 2 HBP | ACC/AHA Stage 1 HBP | ACC/AHA Elevated BP | COR/LOE |
|---|---|---|---|---|---|
| Performance Measures* | |||||
| PM-1a | ACC/AHA stage 2 HBP control SBP <140 mm Hg | + | − | − | COR: 1, LOE: A |
| PM-1b | ACC/AHA stage 2 HBP control SBP <130 mm Hg | + | − | − | COR: 1, LOE: A / COR: 2a, LOE: C-EO |
| PM-2 | ACC/AHA stage 1 HBP control SBP <130 mm Hg | − | + | − | COR: 1, LOE: A |
| PM-3 | ACC/AHA stage 2 and stage 1 HBP control SBP <130 mm Hg (composite measure combining PM-1b and PM-2) | + | + | − | COR: 1, LOE: A / COR: 2a, LOE: C-EO |
| PM-4 | Nonpharmacological interventions for ACC/AHA stage 2 HBP | + | − | − | COR: 1, LOE: A |
| PM-5 | Use of HBPM for management of ACC/AHA stage 2 HBP | + | − | − | COR: 1, LOE: A |
| Process Quality Measures* | |||||
| QM-1 | Nonpharmacological interventions for ACC/AHA stage elevated BP | − | − | + | COR: 1, LOE: A |
| QM-2 | Nonpharmacological interventions for ACC/AHA stage 1 HBP | − | + | − | COR: 1, LOE: A |
| QM-3 | Nonpharmacological interventions for all ACC/AHA stages of HBP (composite measure combining PM-4, QM-1, and QM-2) | + | + | + | COR: 1, LOE: A |
| QM-4 | Medication adherence to drug therapy for ACC/AHA stage 1 with ASCVD risk ≥10% or ACC/AHA stage 2 HBP | + | + | − | COR: 1, LOE: A |
| QM-5 | Use of HBPM for management of ACC/AHA stage 1 HBP | − | + | − | COR: 1, LOE: A |
| QM-6 | Use of HBPM for management of ACC/AHA stage 1 or ACC/AHA stage 2 (composite measure combining PM-5 and QM-5) | + | + | − | COR: 1, LOE: A |
Performance measures are used in national quality payment and reporting programs, whereas process quality measures support quality improvement initiatives and activities at the national or microsystem levels.
+Indicates the corresponding ACC/AHA stage for the measure. −Indicates that the ACC/AHA stage does not correspond to the measure.
ACC indicates American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; COR, Class of Recommendation; HBP, high blood pressure; HBPM, home blood pressure monitoring; LOE, Level of Evidence; PM, performance measure; QM, quality measure; and SBP, systolic blood pressure.